Federal investigators discovered a human remains trade with connections to Harvard Medical School and have arrested people in several states
After the bodies are used for research or education, some schools may offer to return the cremated remains to the family or bury them in a cemetery, Marsh said. Lodge, who was charged in the scheme, was a former manager at the Harvard Medical School morgue.
He took the body parts from Harvard’s morgue without the school’s knowledge or permission, federal prosecutors said. The body parts in Pauley’s case were originally donated to the University of Arkansas for medical research. They ended up being stolen from a mortuary where they were supposed to be cremated, authorities said.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Phenotypic variability to medication management: an update on fragile X syndrome - Human GenomicsThis review discusses the discovery, epidemiology, pathophysiology, genetic etiology, molecular diagnosis, and medication-based management of fragile X syndrome (FXS). It also highlights the syndrome’s variable expressivity and common comorbid and overlapping conditions. FXS is an X-linked dominant disorder associated with a wide spectrum of clinical features, including but not limited to intellectual disability, autism spectrum disorder, language deficits, macroorchidism, seizures, and anxiety. Its prevalence in the general population is approximately 1 in 5000–7000 men and 1 in 4000–6000 women worldwide. FXS is associated with the fragile X messenger ribonucleoprotein 1 (FMR1) gene located at locus Xq27.3 and encodes the fragile X messenger ribonucleoprotein (FMRP). Most individuals with FXS have an FMR1 allele with | 200 CGG repeats (full mutation) and hypermethylation of the CpG island proximal to the repeats, which silences the gene’s promoter. Some individuals have mosaicism in the size of the CGG repeats or in hypermethylation of the CpG island, both produce some FMRP and give rise to milder cognitive and behavioral deficits than in non-mosaic individuals with FXS. As in several monogenic disorders, modifier genes influence the penetrance of FMR1 mutations and FXS’s variable expressivity by regulating the pathophysiological mechanisms related to the syndrome’s behavioral features. Although there is no cure for FXS, prenatal molecular diagnostic testing is recommended to facilitate early diagnosis. Pharmacologic agents can reduce some behavioral features of FXS, and researchers are investigating whether gene editing can be used to demethylate the FMR1 promoter region to improve patient outcomes. Moreover, clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 and developed nuclease defective Cas9 (dCas9) strategies have promised options of genome editing in gain-of-function mutations to rewrite new genetic information into a specified DNA site, are
Read more »
'Human time bomb': The fiend who terrorised the Gorbals for decadesThe human time bomb terrorised the Gorbals for decades.
Read more »
List of 18 medical conditions that could see you banned from flying this summerAirlines have the right to refuse boarding to anyone who is suffering from certain ailments.
Read more »
Shang-Chi star Simu Liu wants to share screen with fellow MCU hero'She's just such a wonderful human being.'
Read more »